Weight loss pens can cost over 3,000 euros a year, even with state help
Starting in February 2027, the state will provide a 15% subsidy for weight loss medication (such as Wegovy, Mounjaro, or Saxenda) for patients with a clinical file in the PCIPO program and active follow-up by a public hospital multidisciplinary obesity team (EMO). This subsidy lasts for 12 months after the first dispensing, after which the continuity of support remains unclear.

